FDA Warning Letter — Vertical Pharmaceuticals, LLC
The FDA took a Warning Letter action against Vertical Pharmaceuticals, LLC on May 10, 2017 (Sayreville, NJ). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Vertical Pharmaceuticals, LLC
- Date
- May 10, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Center
- CDER
- Location
- Sayreville, NJ (United States)